The acquisition of Fertin Pharma advances PMI’s goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine. Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin…